SG&A at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's sg&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Microbot Medical's SG&A?
- Microbot Medical (MBOT) reported SG&A of $3.03M in Q1 2026.
- How has Microbot Medical's SG&A changed year-over-year?
- Microbot Medical's SG&A increased by 93.9% year-over-year, from $1.56M to $3.03M.
- What does SG&A mean?
- Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.